Picture of LungLife AI logo

LLAI — LungLife AI News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Lunglife AI Says Medicare Grants Pricing For Lunglb® Early Lung Cancer Diagnostic

Nov 30 (Reuters) - LungLife AI Inc  LLAI.L :
    * MEDICARE GRANTS PRICING FOR LUNGLIFE'S LUNGLB® EARLY LUNG
CANCER
DIAGNOSTIC
    * MEDICARE GRANTED A PRICE AT $2,030 PER TEST FOR LUNGLB
EARLY
LUNG CANCER DETECTION DIAGNOSTIC

Source text for Eikon:  ID:nRSd0001Ia 
Further company coverage:  LLAI.L 
 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on LungLife AI

See all news